{"parse":{"title":"Biological patent","pageid":39666891,"revid":835391069,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"vertical-navbox nowraplinks\" style=\"float:right;clear:right;width:22.0em;margin:0 0 1.0em 1.0em;background:#f9f9f9;border:1px solid #aaa;padding:0.2em;border-spacing:0.4em 0;text-align:center;line-height:1.4em;font-size:88%\"><tbody><tr><th style=\"padding:0.2em 0.4em 0.2em;font-size:145%;line-height:1.2em\"><a href=\"/wiki/Patent\" title=\"Patent\">Patent</a> law</th></tr><tr><th style=\"padding:0.1em;background:#aaddff; color:#000;\">\nOverviews</th></tr><tr><td class=\"hlist\" style=\"padding:0 0.1em 0.4em\">\n<ul><li><a href=\"/wiki/Patent\" title=\"Patent\">Patents</a></li>\n<li><a href=\"/wiki/History_of_patent_law\" title=\"History of patent law\">History</a></li>\n<li><a href=\"/wiki/Economics_and_patents\" title=\"Economics and patents\">Economics</a></li>\n<li><a href=\"/wiki/Societal_views_on_patents\" title=\"Societal views on patents\">Societal views</a></li></ul></td>\n</tr><tr><th style=\"padding:0.1em;background:#aaddff; color:#000;\">\nBasic concepts</th></tr><tr><td class=\"hlist\" style=\"padding:0 0.1em 0.4em\">\n<ul><li><a href=\"/wiki/Patent_application\" title=\"Patent application\">Application</a></li>\n<li><a href=\"/wiki/Patent_prosecution\" title=\"Patent prosecution\">Prosecution</a></li>\n<li><a href=\"/wiki/Opposition_proceeding#Patents\" title=\"Opposition proceeding\">Opposition</a></li>\n<li><a href=\"/wiki/License#Intellectual_property\" title=\"License\">Licensing</a></li>\n<li><a href=\"/wiki/Patent_infringement\" title=\"Patent infringement\">Infringement</a></li>\n<li><a href=\"/wiki/Patent_valuation\" title=\"Patent valuation\">Valuation</a></li>\n<li><a href=\"/wiki/Patent_claim\" title=\"Patent claim\">Patent claims</a></li></ul></td>\n</tr><tr><th style=\"padding:0.1em;background:#aaddff; color:#000;\">\n<a href=\"/wiki/Patentability\" title=\"Patentability\">Patentability</a></th></tr><tr><td class=\"hlist\" style=\"padding:0 0.1em 0.4em\">\n<ul><li><a href=\"/wiki/Novelty_(patent)\" title=\"Novelty (patent)\">Novelty</a></li>\n<li><a href=\"/wiki/Inventive_step_and_non-obviousness\" title=\"Inventive step and non-obviousness\">Inventive step and non-obviousness</a></li>\n<li><a href=\"/wiki/Inventor_(patent)\" title=\"Inventor (patent)\">Inventorship</a></li>\n<li><a href=\"/wiki/Industrial_applicability\" title=\"Industrial applicability\">Industrial applicability</a></li>\n<li><a href=\"/wiki/Patentable_subject_matter\" title=\"Patentable subject matter\">Patentable subject matter</a></li>\n<li><a href=\"/wiki/Person_having_ordinary_skill_in_the_art\" title=\"Person having ordinary skill in the art\">Person skilled in the art</a></li>\n<li><a href=\"/wiki/Prior_art\" title=\"Prior art\">Prior art</a></li>\n<li><a href=\"/wiki/Utility_(patent)\" title=\"Utility (patent)\">Utility</a></li></ul></td>\n</tr><tr><th style=\"padding:0.1em;background:#aaddff; color:#000;\">\nAdditional requirements</th></tr><tr><td class=\"hlist\" style=\"padding:0 0.1em 0.4em\">\n<ul><li><a href=\"/wiki/Sufficiency_of_disclosure\" title=\"Sufficiency of disclosure\">Sufficiency of disclosure</a></li>\n<li><a href=\"/wiki/Unity_of_invention\" title=\"Unity of invention\">Unity of invention</a></li></ul></td>\n</tr><tr><th style=\"padding:0.1em;background:#aaddff; color:#000;\">\nBy region&#160;/&#32;country</th></tr><tr><td class=\"hlist\" style=\"padding:0 0.1em 0.4em\">\n<ul><li><a href=\"/wiki/Patent_Cooperation_Treaty\" title=\"Patent Cooperation Treaty\">Patent Cooperation Treaty</a> (PCT)</li></ul>\n<ul><li><a href=\"/wiki/Australian_patent_law\" title=\"Australian patent law\">Australia</a></li>\n<li><a href=\"/wiki/Canadian_patent_law\" title=\"Canadian patent law\">Canada</a></li>\n<li><a href=\"/wiki/Patent_law_of_the_People%27s_Republic_of_China\" title=\"Patent law of the People&#39;s Republic of China\">China</a></li>\n<li><a href=\"/wiki/European_patent_law\" title=\"European patent law\">Europe</a></li>\n<li><a href=\"/wiki/German_patent_law\" title=\"German patent law\">Germany</a></li>\n<li><a href=\"/wiki/Japanese_patent_law\" title=\"Japanese patent law\">Japan</a></li>\n<li><a href=\"/wiki/Patent_law_in_the_Netherlands\" title=\"Patent law in the Netherlands\">Netherlands</a></li>\n<li><a href=\"/wiki/United_States_patent_law\" title=\"United States patent law\">United States</a></li></ul></td>\n</tr><tr><th style=\"padding:0.1em;background:#aaddff; color:#000;\">\nBy specific subject matter</th></tr><tr><td class=\"hlist\" style=\"padding:0 0.1em 0.4em\">\n<ul><li><a class=\"mw-selflink selflink\">Biological</a></li>\n<li><a href=\"/wiki/Business_method_patent\" title=\"Business method patent\">Business method</a></li>\n<li><a href=\"/wiki/Chemical_patent\" title=\"Chemical patent\">Chemical</a></li>\n<li><a href=\"/wiki/Insurance_patent\" title=\"Insurance patent\">Insurance</a></li>\n<li><a href=\"/wiki/Software_patent\" title=\"Software patent\">Software</a></li>\n<li><a href=\"/wiki/Tax_patent\" title=\"Tax patent\">Tax</a></li></ul></td>\n</tr><tr><th style=\"padding:0.1em;background:#aaddff; color:#000;\">\nSee also</th></tr><tr><td class=\"hlist\" style=\"padding:0 0.1em 0.4em\">\n<ul><li><a href=\"/wiki/Category:Patent_law\" title=\"Category:Patent law\">Category</a></li>\n<li><a href=\"/wiki/Glossary_of_patent_law_terms\" title=\"Glossary of patent law terms\">Glossary</a></li></ul></td>\n</tr><tr><td style=\"text-align:right;font-size:115%\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Patent_law\" title=\"Template:Patent law\"><abbr title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Patent_law\" title=\"Template talk:Patent law\"><abbr title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Patent_law&amp;action=edit\"><abbr title=\"Edit this template\">e</abbr></a></li></ul></div></td></tr></tbody></table>\n<p>A <b>biological patent</b> is a <a href=\"/wiki/Patent\" title=\"Patent\">patent</a> on an <a href=\"/wiki/Invention\" title=\"Invention\">invention</a> in the field of <a href=\"/wiki/Biology\" title=\"Biology\">biology</a> that by law allows the patent holder to exclude others from making, using, selling, or importing the protected invention for <a href=\"/wiki/Term_of_patent\" title=\"Term of patent\">a limited period of time</a>. The scope and reach of biological patents vary among jurisdictions,<sup id=\"cite_ref-GEN_1-0\" class=\"reference\"><a href=\"#cite_note-GEN-1\">&#91;1&#93;</a></sup> and may include biological technology and products, <a href=\"/wiki/Genetically_modified_organisms\" class=\"mw-redirect\" title=\"Genetically modified organisms\">genetically modified organisms</a> and <a href=\"/wiki/Genetic_material\" class=\"mw-redirect\" title=\"Genetic material\">genetic material</a>. The applicability of patents to substances and processes wholly or partially natural in origin is a subject of debate.<sup id=\"cite_ref-GEN_1-1\" class=\"reference\"><a href=\"#cite_note-GEN-1\">&#91;1&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Biological_patents_in_different_jurisdictions\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Biological patents in different jurisdictions</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Australia\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Australia</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Europe\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Europe</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Japan\"><span class=\"tocnumber\">1.3</span> <span class=\"toctext\">Japan</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#United_States\"><span class=\"tocnumber\">1.4</span> <span class=\"toctext\">United States</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Ethics\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Ethics</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Biological_patents_in_different_jurisdictions\">Biological patents in different jurisdictions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Biological_patent&amp;action=edit&amp;section=1\" title=\"Edit section: Biological patents in different jurisdictions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Australia\">Australia</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Biological_patent&amp;action=edit&amp;section=2\" title=\"Edit section: Australia\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In February 2013, Judge [Justice John Nicholas] ruled in the <a href=\"/wiki/Federal_Court_of_Australia\" title=\"Federal Court of Australia\">Federal Court of Australia</a> in favour of a Myriad Genetics patent on the <a href=\"/wiki/BRCA1\" title=\"BRCA1\">BRCA1</a> gene.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> This was a landmark ruling, affirming the validity of patents on naturally occurring <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a> sequences. However, the U.S. Supreme Court came to the opposite conclusion only a few months later.  The Australian ruling has been appealed to the Full Bench of the Federal Court; submissions in the case include consideration of the U.S. Supreme Court ruling.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> This decision was decided in 2014, affirming Nicholas J's decision in favor of Myriad, confirming that isolated genetic material (genes) are valid subjects of patents.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>  As of June 2015 the case was pending hearing in the High Court of Australia.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> In October 2015 the Australian high court ruled that naturally occurring genes cannot be patented.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Europe\">Europe</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Biological_patent&amp;action=edit&amp;section=3\" title=\"Edit section: Europe\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a> directive <a href=\"/wiki/Directive_98/44/EC\" class=\"mw-redirect\" title=\"Directive 98/44/EC\">98/44/EC</a> (the <i>Biotech Directive</i>) reconciled the legislation of biological patents among certain countries under the jurisdiction of the <a href=\"/wiki/European_Patent_Organisation\" title=\"European Patent Organisation\">European Patent Organisation</a>.<sup id=\"cite_ref-GEN_1-2\" class=\"reference\"><a href=\"#cite_note-GEN-1\">&#91;1&#93;</a></sup> It allows for the patenting of natural biological products, including gene sequences, as long as they are \"isolated from [their] natural environment or produced by means of a technical process.\"<sup id=\"cite_ref-GEN_1-3\" class=\"reference\"><a href=\"#cite_note-GEN-1\">&#91;1&#93;</a></sup>\n</p><p>The <a href=\"/wiki/European_Patent_Office\" title=\"European Patent Office\">European Patent Office</a> has <a href=\"/wiki/G_2/06\" title=\"G 2/06\">ruled</a> that European patents cannot be granted for processes that involve the destruction of human embryos.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Japan\">Japan</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Biological_patent&amp;action=edit&amp;section=4\" title=\"Edit section: Japan\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Under the umbrella of biotechnology, applications for patents on biological inventions are examined according to general guidelines for patents. In response to requests for additional clarity, the <a href=\"/wiki/Japan_Patent_Office\" title=\"Japan Patent Office\">Japan Patent Office</a> (JPO) set forth specific guidelines for biology-related inventions. Over the years, the JPO has continued to amend these guidelines to clarify their application to new technologies. These amendments have broadened the scope of patents within the biotechnology industry. The Japanese Patent Act requires that patented inventions be \u201cindustrially applicable\u201d, i.e. they must have market or commercial potential. The JPO explicitly lists \u201cmedical activities\u201d among inventions that fall outside the scope of industrially applicable inventions, meaning that methods of surgery, therapy, and the diagnosis of human diseases cannot be patented.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"United_States\">United States</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Biological_patent&amp;action=edit&amp;section=5\" title=\"Edit section: United States\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Biological_patents_in_the_United_States\" title=\"Biological patents in the United States\">Biological patents in the United States</a></div>\n<p>In the United States, up until 2013 natural biological substances themselves could have been patented (apart from any associated process or usage) if they were sufficiently \"isolated\" from their naturally occurring states. Prominent historical examples of such patents include those on <a href=\"/wiki/Adrenaline\" title=\"Adrenaline\">adrenaline</a>,<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> <a href=\"/wiki/Insulin\" title=\"Insulin\">insulin</a>,<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> <a href=\"/wiki/Vitamin_B12\" title=\"Vitamin B12\">vitamin B<sub>12</sub></a>,<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> and various genes.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup> A <a href=\"/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics\" class=\"mw-redirect\" title=\"Association for Molecular Pathology v. Myriad Genetics\">landmark ruling</a> by the <a href=\"/wiki/U.S._Supreme_Court\" class=\"mw-redirect\" title=\"U.S. Supreme Court\">U.S. Supreme Court</a> in June 2013 declared naturally occurring DNA sequences ineligible for patents.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Ethics\">Ethics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Biological_patent&amp;action=edit&amp;section=6\" title=\"Edit section: Ethics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The patenting of <a href=\"/wiki/Genes\" class=\"mw-redirect\" title=\"Genes\">genes</a> is a controversial issue in terms of <a href=\"/wiki/Bioethics\" title=\"Bioethics\">bioethics</a>. Some believe it is unethical to patent genetic material because it treats life as a commodity, or that it undermines the dignity of people and animals by allowing ownership of genes.<sup id=\"cite_ref-two_15-0\" class=\"reference\"><a href=\"#cite_note-two-15\">&#91;15&#93;</a></sup> Some say that living materials occur naturally, and therefore cannot be patented.<sup id=\"cite_ref-one_16-0\" class=\"reference\"><a href=\"#cite_note-one-16\">&#91;16&#93;</a></sup> The <a href=\"/wiki/American_Medical_Association\" title=\"American Medical Association\">American Medical Association</a>'s stance is that gene patents inhibit access to genetic testing for patients and hinder research on genetic disease.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p><p>While some feel that a patent on living material is unethical, others<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Manual_of_Style/Words_to_watch#Unsupported_attributions\" title=\"Wikipedia:Manual of Style/Words to watch\"><span title=\"The material near this tag possibly uses too-vague attribution or weasel words. (November 2013)\">who?</span></a></i>&#93;</sup> believe that not allowing patents on biotechnological inventions would also be unethical. Supporters of this idea suggest that patents allow the public, as well as policy makers, to hold the owner of the patent(s) accountable. They favor biological patents because they require disclosure of information to the public.<sup id=\"cite_ref-three_18-0\" class=\"reference\"><a href=\"#cite_note-three-18\">&#91;18&#93;</a></sup> Agreements such as the <a href=\"/wiki/Agreement_on_Trade-related_Aspects_of_Intellectual_Property_Rights\" class=\"mw-redirect\" title=\"Agreement on Trade-related Aspects of Intellectual Property Rights\">Agreement on Trade-related Aspects of Intellectual Property Rights</a> (TRIPS) require members of the <a href=\"/wiki/World_Trade_Organization\" title=\"World Trade Organization\">World Trade Organization</a> (WTO) to have intellectual property protection laws in place for most biological innovation, making it unlikely that many countries will prohibit patents on genes altogether.<sup id=\"cite_ref-one_16-1\" class=\"reference\"><a href=\"#cite_note-one-16\">&#91;16&#93;</a></sup> Some<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Manual_of_Style/Words_to_watch#Unsupported_attributions\" title=\"Wikipedia:Manual of Style/Words to watch\"><span title=\"The material near this tag possibly uses too-vague attribution or weasel words. (November 2013)\">who?</span></a></i>&#93;</sup> say that patenting genes only commodifies life if a patent applies to an entire human being, arguing that<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Manual_of_Style/Words_to_watch#Unsupported_attributions\" title=\"Wikipedia:Manual of Style/Words to watch\"><span title=\"The material near this tag possibly uses too-vague attribution or weasel words. (November 2013)\">who?</span></a></i>&#93;</sup> patents on single body parts do not violate human dignity.<sup id=\"cite_ref-four_19-0\" class=\"reference\"><a href=\"#cite_note-four-19\">&#91;19&#93;</a></sup>\n</p><p>Another area of controversy in genetic patenting is how gene samples are obtained. Prior consent is required to collect genetic samples, and collection of samples from people requires consent at the national and community levels as well as the individual level. Conflicts have resulted when consent is not obtained at all three levels. The question of benefit sharing also arises when obtaining genetic samples, specifically the potential responsibility of the collector to share any benefits or profits of the discoveries with the population or person from whom the sample came.<sup id=\"cite_ref-one_16-2\" class=\"reference\"><a href=\"#cite_note-one-16\">&#91;16&#93;</a></sup>\n</p><p>The last major ethical issue involving gene patents is how the patents are used post-issuance. A major concern<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Manual_of_Style/Words_to_watch#Unsupported_attributions\" title=\"Wikipedia:Manual of Style/Words to watch\"><span title=\"The material near this tag possibly uses too-vague attribution or weasel words. (November 2013)\">who?</span></a></i>&#93;</sup> is that the use of patented materials and processes will be very expensive or even prohibited to some degree by conditions the patent owner sets.<sup id=\"cite_ref-five_20-0\" class=\"reference\"><a href=\"#cite_note-five-20\">&#91;20&#93;</a></sup> Limiting access like this would directly impact agricultural institutes and university researchers, among others. Some<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Manual_of_Style/Words_to_watch#Unsupported_attributions\" title=\"Wikipedia:Manual of Style/Words to watch\"><span title=\"The material near this tag possibly uses too-vague attribution or weasel words. (November 2013)\">who?</span></a></i>&#93;</sup> fear that holders of biotechnology patents would exploit their rights in order to make larger profits, at the potential expense of farmers, healthcare patients, and other users of patented technologies.\n</p><p>The ethics of using patents to increase profits are also debated. A typical argument in favor of biotech patents is that they enable companies to earn money that the companies in turn invest in further research. Without these patents, some worry that companies would no longer have the resources or motives to perform competitive, viable biotech research.<sup id=\"cite_ref-one_16-3\" class=\"reference\"><a href=\"#cite_note-one-16\">&#91;16&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Biological_patent&amp;action=edit&amp;section=7\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Bioprospecting\" title=\"Bioprospecting\">Bioprospecting and biopiracy</a></li>\n<li><a href=\"/wiki/Budapest_Treaty\" title=\"Budapest Treaty\">Budapest Treaty</a></li>\n<li><a href=\"/wiki/Human_Genome_Project\" title=\"Human Genome Project\">Human Genome Project</a></li>\n<li><a href=\"/wiki/The_Lens\" class=\"mw-redirect\" title=\"The Lens\">The Lens</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Biological_patent&amp;action=edit&amp;section=8\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-GEN-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-GEN_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-GEN_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-GEN_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-GEN_1-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Sharples, Andrew (2011-03-23). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.genengnews.com/insight-and-intelligenceand153/gene-patents-in-europe-relatively-stable-despite-uncertainty-in-the-u-s/77899385/\">\"Gene Patents in Europe Relatively Stable Despite Uncertainty in the U.S.\"</a> <i>Genetic Engineering and Biotechnology News</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2013-06-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+and+Biotechnology+News&amp;rft.atitle=Gene+Patents+in+Europe+Relatively+Stable+Despite+Uncertainty+in+the+U.S.&amp;rft.date=2011-03-23&amp;rft.au=Sharples%2C+Andrew&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Finsight-and-intelligenceand153%2Fgene-patents-in-europe-relatively-stable-despite-uncertainty-in-the-u-s%2F77899385%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Corderoy, Amy (February 15, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.smh.com.au/national/health/landmark-patent-ruling-over-breast-cancer-gene-brca1-20130215-2egsq.html\">\"Landmark patent ruling over breast cancer gene BRCA1\"</a>. <i><a href=\"/wiki/Sydney_Morning_Herald\" class=\"mw-redirect\" title=\"Sydney Morning Herald\">Sydney Morning Herald</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 14,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sydney+Morning+Herald&amp;rft.atitle=Landmark+patent+ruling+over+breast+cancer+gene+BRCA1&amp;rft.date=2013-02-15&amp;rft.aulast=Corderoy&amp;rft.aufirst=Amy&amp;rft_id=http%3A%2F%2Fwww.smh.com.au%2Fnational%2Fhealth%2Flandmark-patent-ruling-over-breast-cancer-gene-brca1-20130215-2egsq.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Corderoy, Amy (March 4, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.smh.com.au/national/brca1-gene-patent-ruling-to-be-appealed-20130304-2fg1f.html\">\"BRCA1 gene patent ruling to be appealed\"</a>. <i><a href=\"/wiki/Sydney_Morning_Herald\" class=\"mw-redirect\" title=\"Sydney Morning Herald\">Sydney Morning Herald</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 14,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sydney+Morning+Herald&amp;rft.atitle=BRCA1+gene+patent+ruling+to+be+appealed&amp;rft.date=2013-03-04&amp;rft.aulast=Corderoy&amp;rft.aufirst=Amy&amp;rft_id=http%3A%2F%2Fwww.smh.com.au%2Fnational%2Fbrca1-gene-patent-ruling-to-be-appealed-20130304-2fg1f.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Corderoy, Amy (June 14, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.smh.com.au/technology/sci-tech/companies-cant-patent-genes-us-court-rules-20130614-2o836.html\">\"Companies can't patent genes, US court rules\"</a>. <i><a href=\"/wiki/Sydney_Morning_Herald\" class=\"mw-redirect\" title=\"Sydney Morning Herald\">Sydney Morning Herald</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">June 14,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sydney+Morning+Herald&amp;rft.atitle=Companies+can%27t+patent+genes%2C+US+court+rules&amp;rft.date=2013-06-14&amp;rft.aulast=Corderoy&amp;rft.aufirst=Amy&amp;rft_id=http%3A%2F%2Fwww.smh.com.au%2Ftechnology%2Fsci-tech%2Fcompanies-cant-patent-genes-us-court-rules-20130614-2o836.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.timebase.com.au/news/2014/AT499-article.html\">\"Full Federal Court Upholds Gene Patents: D'Arcy v Myriad Genetics Inc &#91;2014&#93; FCAFC 115\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Full+Federal+Court+Upholds+Gene+Patents%3A+D%E2%80%99Arcy+v+Myriad+Genetics+Inc+%5B2014%5D+FCAFC+115&amp;rft_id=http%3A%2F%2Fwww.timebase.com.au%2Fnews%2F2014%2FAT499-article.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.hcourt.gov.au/cases/case_s28-2015\">\"D'Arcy v. Myriad Genetics Inc &amp; Anor\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=D%27Arcy+v.+Myriad+Genetics+Inc+%26+Anor&amp;rft_id=http%3A%2F%2Fwww.hcourt.gov.au%2Fcases%2Fcase_s28-2015&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\">Genes can\u2019t be patented, rules Australia\u2019s high court. (2015, October 7). Retrieved 10 November 2015, from <a rel=\"nofollow\" class=\"external free\" href=\"https://www.newscientist.com/article/gene-patents-struck-down-by-australias-high-court/\">https://www.newscientist.com/article/gene-patents-struck-down-by-australias-high-court/</a></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://archive.epo.org/epo/pubs/oj009/05_09/05_3069.pdf\">Decision G2/06 of 25 November 2008, WARF/Stem Cells</a> (OJ EPO 2009, 306). See also <a rel=\"nofollow\" class=\"external text\" href=\"http://www.epo.org/law-practice/case-law-appeals/pdf/t102221eu1.pdf\">Decision T 2221/10 of 4 February 2014, Culturing stem cells/TECHNION</a>.</span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"http://sugi.pat.co.jp/wp-content/uploads/2013/05/WIPR-2013-Annual_Page_1.pdf\"><i>iPS Cell Technology Spurs Biological Patenting in Japan</i></a> <span style=\"font-size:85%;\">(PDF)</span>, <a href=\"/wiki/World_Intellectual_Property_Review\" title=\"World Intellectual Property Review\">World Intellectual Property Review</a>, May 2013</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=iPS+Cell+Technology+Spurs+Biological+Patenting+in+Japan&amp;rft.pub=World+Intellectual+Property+Review&amp;rft.date=2013-05&amp;rft_id=http%3A%2F%2Fsugi.pat.co.jp%2Fwp-content%2Fuploads%2F2013%2F05%2FWIPR-2013-Annual_Page_1.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Crouch D (23 May 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://patentlyo.com/patent/2012/05/myriad-parke-davis.html\">\"Guest Post: Myriad Misunderstanding of Parke-Davis v. Mulford\"</a>. <i>Patentlyo</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 Mar</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Patentlyo&amp;rft.atitle=Guest+Post%3A+Myriad+Misunderstanding+of+Parke-Davis+v.+Mulford&amp;rft.date=2012-05-23&amp;rft.aulast=Crouch&amp;rft.aufirst=D&amp;rft_id=https%3A%2F%2Fpatentlyo.com%2Fpatent%2F2012%2F05%2Fmyriad-parke-davis.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.hopkinsmedicine.org/news/media/releases/why_people_with_diabetes_cant_buy_generic_insulin\">\"Why People with Diabetes Can't Buy Generic Insulin\"</a>. <i>Johns Hopkins Medicine</i>. 18 Mar 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 Mar</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Johns+Hopkins+Medicine&amp;rft.atitle=Why+People+with+Diabetes+Can%E2%80%99t+Buy+Generic+Insulin&amp;rft.date=2015-03-18&amp;rft_id=http%3A%2F%2Fwww.hopkinsmedicine.org%2Fnews%2Fmedia%2Freleases%2Fwhy_people_with_diabetes_cant_buy_generic_insulin&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Zuhn D (9 Jun 2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.patentdocs.org/2009/06/gene-patenting-debate-continues.html\">\"Gene Patenting Debate Continues\"</a>. <i>PatentDocs: Biotech &amp; Pharma Patent Law &amp; News Blog</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 Mar</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PatentDocs%3A+Biotech+%26+Pharma+Patent+Law+%26+News+Blog&amp;rft.atitle=Gene+Patenting+Debate+Continues&amp;rft.date=2009-06-09&amp;rft.aulast=Zuhn&amp;rft.aufirst=D&amp;rft_id=http%3A%2F%2Fwww.patentdocs.org%2F2009%2F06%2Fgene-patenting-debate-continues.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cook-Deegan R, Heaney C (22 Sep 2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2935940\">\"Patents in Genomics and Human Genetics\"</a>. <i>Annu Rev Genom Hum Genet</i>. <b>11</b>: 383\u2013425. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1146/annurev-genom-082509-141811\">10.1146/annurev-genom-082509-141811</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2935940\">2935940</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20590431\">20590431</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annu+Rev+Genom+Hum+Genet&amp;rft.atitle=Patents+in+Genomics+and+Human+Genetics&amp;rft.volume=11&amp;rft.pages=383-425&amp;rft.date=2010-09-22&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2935940&amp;rft_id=info%3Apmid%2F20590431&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev-genom-082509-141811&amp;rft.aulast=Cook-Deegan&amp;rft.aufirst=R&amp;rft.au=Heaney%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2935940&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><i><a href=\"/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics\" class=\"mw-redirect\" title=\"Association for Molecular Pathology v. Myriad Genetics\">Association for Molecular Pathology v. Myriad Genetics</a></i>, 569 U.S. ___ (2013) <a rel=\"nofollow\" class=\"external autonumber\" href=\"https://www.supremecourt.gov/opinions/12pdf/12-398_8njq.pdf\">[1]</a></span>\n</li>\n<li id=\"cite_note-two-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-two_15-0\">^</a></b></span> <span class=\"reference-text\">Dresser R. 1988. Ethical and Legal Issues in Patenting New Animal Life. Jurimetrics 28:399-435</span>\n</li>\n<li id=\"cite_note-one-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-one_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-one_16-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-one_16-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-one_16-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\">Marchant GE. 2007. Genomics, Ethics, and Intellectual Property. Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices. Ch 1.5:29-38</span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/related-policy-topics/gene-patenting.page?\">\"Gene Patenting\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Gene+Patenting&amp;rft_id=http%3A%2F%2Fwww.ama-assn.org%2Fama%2Fpub%2Fphysician-resources%2Fmedical-science%2Fgenetics-molecular-medicine%2Frelated-policy-topics%2Fgene-patenting.page%3F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-three-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-three_18-0\">^</a></b></span> <span class=\"reference-text\">Caulfield TA, Gold ER. 2000. Genetic Testing. Ethical Concerns, and the Role of Patent Law. Clinical Genetics 57:370-75</span>\n</li>\n<li id=\"cite_note-four-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-four_19-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Resnik, DB (2001). \"DNA Patents and Human dignity\". <i>The Journal of Law, Medicine &amp; Ethics</i>. <b>29</b> (1): 152\u2013165.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Law%2C+Medicine+%26+Ethics&amp;rft.atitle=DNA+Patents+and+Human+dignity&amp;rft.volume=29&amp;rft.issue=1&amp;rft.pages=152-165&amp;rft.date=2001&amp;rft.aulast=Resnik&amp;rft.aufirst=DB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-five-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-five_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Andrews, LB (2000). \"Genes and Patent Policy: Rethinking IP Rights\". <i>Nature Reviews Genetics</i>. <b>3</b>: 803\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrg909\">10.1038/nrg909</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Genetics&amp;rft.atitle=Genes+and+Patent+Policy%3A+Rethinking+IP+Rights&amp;rft.volume=3&amp;rft.pages=803-8&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1038%2Fnrg909&amp;rft.aulast=Andrews&amp;rft.aufirst=LB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABiological+patent\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Biological_patent&amp;action=edit&amp;section=9\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>Relevant legal provisions of the European Patent Convention:\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.epo.org/law-practice/legal-texts/html/epc/2013/e/ar53.html\">Article 53(a)</a> <a href=\"/wiki/European_Patent_Convention\" title=\"European Patent Convention\">EPC</a>: \"Exceptions to patentability\" (formerly <a rel=\"nofollow\" class=\"external text\" href=\"https://www.epo.org/law-practice/legal-texts/html/epc/1973/e/ar53a.html\">Article 53a</a> <a href=\"/wiki/European_Patent_Convention\" title=\"European Patent Convention\">EPC 1973</a>)</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/r28.html\">Rule 28</a> <a href=\"/wiki/European_Patent_Convention\" title=\"European Patent Convention\">EPC</a>: \"Exceptions to patentability\" (formerly <a rel=\"nofollow\" class=\"external text\" href=\"https://www.epo.org/law-practice/legal-texts/html/epc/1973/e/r23c.html\">Rule 23c</a> <a href=\"/wiki/European_Patent_Convention\" title=\"European Patent Convention\">EPC 1973</a>), barring the patentability of, notably, \"processes for cloning human beings\" (Rule 28(a) EPC); \"processes for modifying the germ line genetic identity of human beings\" (Rule 28(b) EPC); and \"uses of human embryos for industrial or commercial purposes\" (Rule 28(c) EPC)</li></ul></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw2183\nCached time: 20180915020214\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.276 seconds\nReal time usage: 0.337 seconds\nPreprocessor visited node count: 1415/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 45608/2097152 bytes\nTemplate argument size: 3532/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 19056/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.117/10.000 seconds\nLua memory usage: 4.22 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  255.490      1 -total\n 47.86%  122.269      1 Template:Reflist\n 27.40%   70.015      5 Template:Who\n 24.83%   63.443      5 Template:Fix\n 19.26%   49.206      6 Template:Cite_web\n 14.56%   37.192      5 Template:Delink\n 10.75%   27.463      1 Template:Patent_law\n 10.00%   25.541      1 Template:Sidebar\n  8.82%   22.525      5 Template:Category_handler\n  6.42%   16.414      4 Template:Cite_news\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:39666891-0!canonical and timestamp 20180915020214 and revision id 835391069\n -->\n</div>"},"langlinks":[{"lang":"es","url":"https://es.wikipedia.org/wiki/Patente_biol%C3%B3gica","langname":"Spanish","autonym":"espa\u00f1ol","*":"Patente biol\u00f3gica"},{"lang":"eo","url":"https://eo.wikipedia.org/wiki/Biologia_patento","langname":"Esperanto","autonym":"Esperanto","*":"Biologia patento"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E7%94%9F%E7%89%A9%E5%AD%A6%E7%9A%84%E7%89%B9%E8%A8%B1","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u751f\u7269\u5b66\u7684\u7279\u8a31"}],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_specifically_marked_weasel-worded_phrases"},{"sortkey":"","hidden":"","*":"Articles_with_specifically_marked_weasel-worded_phrases_from_November_2013"},{"sortkey":"","*":"Science_and_law"},{"sortkey":" ","*":"Biological_patent_law"},{"sortkey":"","*":"Biotechnology_law"},{"sortkey":"","*":"Emerging_technologies"},{"sortkey":"","*":"Commercialization_of_traditional_medicines"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with specifically marked weasel-worded phrases from November 2013"},{"ns":14,"exists":"","*":"Category:Patent law"},{"ns":10,"exists":"","*":"Template:Patent law"},{"ns":0,"exists":"","*":"Adrenaline"},{"ns":0,"exists":"","*":"Agreement on Trade-related Aspects of Intellectual Property Rights"},{"ns":0,"exists":"","*":"American Medical Association"},{"ns":0,"exists":"","*":"Association for Molecular Pathology v. Myriad Genetics"},{"ns":0,"exists":"","*":"Australian patent law"},{"ns":0,"exists":"","*":"BRCA1"},{"ns":0,"exists":"","*":"Bioethics"},{"ns":0,"exists":"","*":"Biological patents in the United States"},{"ns":0,"exists":"","*":"Biology"},{"ns":0,"exists":"","*":"Bioprospecting"},{"ns":0,"exists":"","*":"Budapest Treaty"},{"ns":0,"exists":"","*":"Business method patent"},{"ns":0,"exists":"","*":"Canadian patent law"},{"ns":0,"exists":"","*":"Chemical patent"},{"ns":0,"exists":"","*":"DNA"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Directive 98/44/EC"},{"ns":0,"exists":"","*":"Economics and patents"},{"ns":0,"exists":"","*":"European Patent Convention"},{"ns":0,"exists":"","*":"European Patent Office"},{"ns":0,"exists":"","*":"European Patent Organisation"},{"ns":0,"exists":"","*":"European Union"},{"ns":0,"exists":"","*":"European patent law"},{"ns":0,"exists":"","*":"Federal Court of Australia"},{"ns":0,"exists":"","*":"G 2/06"},{"ns":0,"exists":"","*":"Genes"},{"ns":0,"exists":"","*":"Genetic material"},{"ns":0,"exists":"","*":"Genetically modified organisms"},{"ns":0,"exists":"","*":"German patent law"},{"ns":0,"exists":"","*":"Glossary of patent law terms"},{"ns":0,"exists":"","*":"History of patent law"},{"ns":0,"exists":"","*":"Human Genome Project"},{"ns":0,"exists":"","*":"Industrial applicability"},{"ns":0,"exists":"","*":"Insulin"},{"ns":0,"exists":"","*":"Insurance patent"},{"ns":0,"exists":"","*":"Invention"},{"ns":0,"exists":"","*":"Inventive step and non-obviousness"},{"ns":0,"exists":"","*":"Inventor (patent)"},{"ns":0,"exists":"","*":"Japan Patent Office"},{"ns":0,"exists":"","*":"Japanese patent law"},{"ns":0,"exists":"","*":"License"},{"ns":0,"exists":"","*":"Novelty (patent)"},{"ns":0,"exists":"","*":"Opposition proceeding"},{"ns":0,"exists":"","*":"Patent"},{"ns":0,"exists":"","*":"Patent Cooperation Treaty"},{"ns":0,"exists":"","*":"Patent application"},{"ns":0,"exists":"","*":"Patent claim"},{"ns":0,"exists":"","*":"Patent infringement"},{"ns":0,"exists":"","*":"Patent law in the Netherlands"},{"ns":0,"exists":"","*":"Patent law of the People's Republic of China"},{"ns":0,"exists":"","*":"Patent prosecution"},{"ns":0,"exists":"","*":"Patent valuation"},{"ns":0,"exists":"","*":"Patentability"},{"ns":0,"exists":"","*":"Patentable subject matter"},{"ns":0,"exists":"","*":"Person having ordinary skill in the art"},{"ns":0,"exists":"","*":"Prior art"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Societal views on patents"},{"ns":0,"exists":"","*":"Software patent"},{"ns":0,"exists":"","*":"Sufficiency of disclosure"},{"ns":0,"exists":"","*":"Sydney Morning Herald"},{"ns":0,"exists":"","*":"Tax patent"},{"ns":0,"exists":"","*":"Term of patent"},{"ns":0,"exists":"","*":"The Lens"},{"ns":0,"exists":"","*":"U.S. Supreme Court"},{"ns":0,"exists":"","*":"United States patent law"},{"ns":0,"exists":"","*":"Unity of invention"},{"ns":0,"exists":"","*":"Utility (patent)"},{"ns":0,"exists":"","*":"Vitamin B12"},{"ns":0,"exists":"","*":"World Intellectual Property Review"},{"ns":0,"exists":"","*":"World Trade Organization"},{"ns":4,"exists":"","*":"Wikipedia:Manual of Style/Words to watch"},{"ns":11,"exists":"","*":"Template talk:Patent law"}],"templates":[{"ns":10,"exists":"","*":"Template:Patent law"},{"ns":10,"exists":"","*":"Template:Sidebar"},{"ns":10,"exists":"","*":"Template:Law sidebar style"},{"ns":10,"exists":"","*":"Template:\\"},{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Who"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:EPC Article"},{"ns":10,"exists":"","*":"Template:EPC 1973 Article"},{"ns":10,"exists":"","*":"Template:EPC Rule"},{"ns":10,"exists":"","*":"Template:EPC 1973 Rule"},{"ns":828,"exists":"","*":"Module:Sidebar"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["http://www.genengnews.com/insight-and-intelligenceand153/gene-patents-in-europe-relatively-stable-despite-uncertainty-in-the-u-s/77899385/","http://www.smh.com.au/national/health/landmark-patent-ruling-over-breast-cancer-gene-brca1-20130215-2egsq.html","http://www.smh.com.au/national/brca1-gene-patent-ruling-to-be-appealed-20130304-2fg1f.html","http://www.smh.com.au/technology/sci-tech/companies-cant-patent-genes-us-court-rules-20130614-2o836.html","http://www.timebase.com.au/news/2014/AT499-article.html","http://www.hcourt.gov.au/cases/case_s28-2015","http://archive.epo.org/epo/pubs/oj009/05_09/05_3069.pdf","http://www.epo.org/law-practice/case-law-appeals/pdf/t102221eu1.pdf","http://sugi.pat.co.jp/wp-content/uploads/2013/05/WIPR-2013-Annual_Page_1.pdf","https://patentlyo.com/patent/2012/05/myriad-parke-davis.html","http://www.hopkinsmedicine.org/news/media/releases/why_people_with_diabetes_cant_buy_generic_insulin","http://www.patentdocs.org/2009/06/gene-patenting-debate-continues.html","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2935940","//doi.org/10.1146/annurev-genom-082509-141811","//www.ncbi.nlm.nih.gov/pubmed/20590431","https://www.supremecourt.gov/opinions/12pdf/12-398_8njq.pdf","http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/related-policy-topics/gene-patenting.page?","//doi.org/10.1038/nrg909","https://www.newscientist.com/article/gene-patents-struck-down-by-australias-high-court/","https://www.epo.org/law-practice/legal-texts/html/epc/2013/e/ar53.html","https://www.epo.org/law-practice/legal-texts/html/epc/1973/e/ar53a.html","https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/r28.html","https://www.epo.org/law-practice/legal-texts/html/epc/1973/e/r23c.html"],"sections":[{"toclevel":1,"level":"2","line":"Biological patents in different jurisdictions","number":"1","index":"1","fromtitle":"Biological_patent","byteoffset":971,"anchor":"Biological_patents_in_different_jurisdictions"},{"toclevel":2,"level":"3","line":"Australia","number":"1.1","index":"2","fromtitle":"Biological_patent","byteoffset":1022,"anchor":"Australia"},{"toclevel":2,"level":"3","line":"Europe","number":"1.2","index":"3","fromtitle":"Biological_patent","byteoffset":3296,"anchor":"Europe"},{"toclevel":2,"level":"3","line":"Japan","number":"1.3","index":"4","fromtitle":"Biological_patent","byteoffset":4204,"anchor":"Japan"},{"toclevel":2,"level":"3","line":"United States","number":"1.4","index":"5","fromtitle":"Biological_patent","byteoffset":5336,"anchor":"United_States"},{"toclevel":1,"level":"2","line":"Ethics","number":"2","index":"6","fromtitle":"Biological_patent","byteoffset":7209,"anchor":"Ethics"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"7","fromtitle":"Biological_patent","byteoffset":11427,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"8","fromtitle":"Biological_patent","byteoffset":11555,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"9","fromtitle":"Biological_patent","byteoffset":11588,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Biological patent","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5465504"}]}}